• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Champions Oncolog (NQ: CSBR )

    4.320 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Champions Oncolog

    < Previous 1 2 3 Next >
    A Preview Of Champions Oncology's Earnings
    Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
    HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... 
    From Champions Oncology, Inc.
    Via AccessWire
    Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
    HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative... 
    From Champions Oncology, Inc.
    Via AccessWire
    Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
    Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
    From Champions Oncology, Inc.
    Via AccessWire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Here's How Much You Would Have Made Owning Champions Oncology Stock In The Last 5 Years
    Champions Oncology (NASDAQ:CSBR) has outperformed the market over the past 5 years by 7.88% on an annualized basis. Buying $1,000 In CSBR: 5 years ago, an investor could have... 
    Via Benzinga
    Champions Oncology Earnings Perspective: Return On Capital Employed
    According to Benzinga Pro, during Q3, Champions Oncology (NASDAQ:CSBR) earned $787.00 thousand, a 184.12% increase from the preceding quarter. Champions Oncology also posted a... 
    Via Benzinga
    Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million
    HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... 
    From Champions Oncology, Inc.
    Via AccessWire
    Earnings Preview For Champions Oncology
    Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts... 
    Via Benzinga
    Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022
    HACKENSACK, NJ / ACCESSWIRE / March 11, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... 
    From Champions Oncology, Inc.
    Via AccessWire
    Earnings Scheduled For March 15, 2022
    Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi... 
    Via Benzinga
    Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
    HACKENSACK, NJ / ACCESSWIRE / February 15, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... 
    From Champions Oncology, Inc.
    Via AccessWire
    Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates
    HACKENSACK, NJ / ACCESSWIRE / January 20, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven... 
    From Champions Oncology, Inc.
    Via AccessWire
    Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs
    HACKENSACK, NJ / ACCESSWIRE / January 4, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative pharmacology,... 
    From Champions Oncology, Inc.
    Via AccessWire
    Looking Into Champions Oncology's Return On Capital Employed
    According to Benzinga Pro, during Q2, Champions Oncology (NASDAQ:CSBR) earned $277.00 thousand, a 261.05% increase from the preceding quarter. Champions Oncology also posted a... 
    Via Benzinga
    Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
    Reported income from operations of $263,000 HACKENSACK, NJ / ACCESSWIRE / December 13, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming... 
    From Champions Oncology, Inc.
    Via AccessWire
    Earnings Scheduled For December 13, 2021
    Companies Reporting Before The Bell • Qudian (NYSE:QD) is projected to report quarterly earnings at $0.18 per share on revenue of $56.15 million. Companies... 
    Via Benzinga
    Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
    HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will report... 
    From Champions Oncology, Inc.
    Via AccessWire
    Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
    HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned... 
    From Champions Oncology, Inc.
    Via AccessWire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers Stealth BioTherapeutics (NASDAQ: 
    Via Benzinga
    Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
    HACKENSACK, NJ / ACCESSWIRE / September 13, 2021 / Champions Oncology, Inc. (Nasdaq:CSBR), leaders in transformative technology solutions utilized in drug discovery and development, today announced its... 
    From Champions Oncology, Inc.
    Via AccessWire
    Topics Earnings
    Exposures Financial
    Earnings Scheduled For September 13, 2021
    Companies Reporting Before The Bell • Optical Cable (NASDAQ:OCC) is expected to report earnings for its third quarter. • NAPCO Security (NASDAQ:NSSC) is estimated... 
    Via Benzinga
    Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021
    HACKENSACK, NJ / ACCESSWIRE / September 2, 2021 / Champions Oncology, Inc. (CSBR), leaders in transformative technology solutionsutilized in oncology drug discovery and development will report its... 
    From Champions Oncology, Inc.
    Via AccessWire
    Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
    HACKENSACK, NJ / ACCESSWIRE / July 26, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider that is transforming drug discovery through innovative... 
    From Champions Oncology, Inc.
    Via AccessWire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Champions Oncology Reports Quarterly Revenue of $10.6 Million
    Record Annual Revenue of $41 Million HACKENSACK, NJ / ACCESSWIRE / July 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in creating transformative technology solutions to be utilized in drug... 
    From Champions Oncology, Inc.
    Via AccessWire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
    HACKENSACK, NJ / ACCESSWIRE / July 14, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative... 
    From Champions Oncology, Inc.
    Via AccessWire
    Earnings Scheduled For July 22, 2021
    Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,... 
    Via Benzinga
    Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions
    HACKENSACK, NJ / ACCESSWIRE / June 15, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced today that they have entered into a strategic partnership with BGI... 
    From Champions Oncology, Inc.
    Via AccessWire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More
    Wall Street analysts expect the biotech industry to grow significantly soon, with the biotech stocks Organogenesis (ORGO​​​​​​​), BioDelivery Sciences (BDSI) and Champions Oncology (CSBR) gaining more... 
    Via Talk Markets
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.